| Review: |
Technetium-99m radiopharmaceuticals are applied to morphological and dynamic imaging of many organs of the body to diagnose various diseases. It is expected that current applications using 99mTc radiopharmaceuticals in renal, hepatic, hepatobiliary, bone, cardiac and oncological disease, as well as other well-entrenched pathologies, will continue to be used for successful patient management. A technical meeting, organised by the IAEA, identified areas of oncology, cardiology, neurology and infection/inflammation imaging where 99mTc radiopharmaceuticals could make substantial contributions in the future. This book is a compilation of 17 papers dealing with the development of radiopharmaceuticals for these areas, each written by a scientist who has extensive experience of the development of 99mTc radiopharmaceuticals in a particular field. |